Navigation Links
Sinovac Reports Positive Preliminary Phase I Clinical Trial Results for EV71 Vaccine in Adult Group
Date:3/10/2011

BEIJING, March 10, 2011 /PRNewswire-Asia/ -- Sinovac Biotech Ltd. (Nasdaq: SVA), a leading provider of biopharmaceutical products in China, announced today the unblinding of the Phase I clinical trial results for the adult population for its proprietary inactivated vaccine against human enterovirus 71 (EV71), which causes hand, foot, and mouth disease (HFMD). The preliminary Phase I results for the EV71 vaccine in adults showed a good safety profile and preliminary immunogenicity profile. Sinovac subsequently initiated the inoculations in the young children and infant groups. The results are anticipated to be provided in the coming months.

Sinovac obtained the approval from the China State Food and Drug Administration (SFDA) to commence clinical trials for its EV71 vaccine on December 23, 2010. The Phase I clinical trial was initiated in the Guangxi Province on December 30 2010. The Phase I design is a single center, randomization, double blinded, and placebo controlled study. The Phase I clinical trial is on track to enroll 168 healthy volunteers in three different groups: adults, young children and infants. The study will evaluate the safety and preliminary immunogenicity profile in the different age groups. The Phase I clinical trial is being conducted in the adult group first and followed by the young children group and then the infant group, starting with a lower dosage followed by a higher dosage.

The inoculations with lower and higher dosages in 36 healthy adult volunteers and the safety observation were completed on February 25, 2011.

The unblinding conference for the Phase I clinical data in the adult group was held on the afternoon of March 9, 2011. The data unblinding conference was supervised under the Data Safety and Monitoring Committee (DSMC) and instructed by the experts from the Ministry of Health, China SFDA and China CDC. There is no severe adv
'/>"/>

SOURCE Sinovac Biotech Ltd.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Sinovac Biotech Submits Clinical Trial Application to SFDA for Pneumococcal Conjugate Vaccine (PCV)
2. Sinovac Provides Preliminary Unaudited Fourth Quarter 2010 Sales Range
3. Sinovacs Stock Exchange Listing Moves to NASDAQ Global Select Market
4. Sinovac Receives SFDA Approval to Commence Clinical Trials for Inactivated Enterovirus Type 71 Vaccine
5. Sinovac Announces Preliminary Unaudited Third Quarter 2010 Sales Range and Revises Full Year 2010 Sales Expectations
6. Sinovac Selected by Beijing CDC to Supply Seasonal Flu Vaccine Anflu(R) to Beijing Citizens
7. Sinovac Receives Drug Registration Certificate from Hong Kong Department of Health for Seasonal Flu Vaccine Anflu(R)
8. Sinovac to Host Conference Call to Report Second Quarter 2010 Financial Results
9. Sinovac Holds 2010 Annual Meeting of Shareholders
10. Sinovac Schedules 2010 Annual Meeting of Shareholders
11. Sinovac Selected by Beijing CDC to Supply Hepatitis A Vaccine Healive(R)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/3/2015)... Research and Markets ( http://www.researchandmarkets.com/research/84p6xc/investigation ) ... on China,s Bromhexine Market, 2010-2019" report to their ... of respiratory disease keeps growing and so does the ... of vasicine, is a mucolytic agent used in the ... or excessive mucus. It can make the phlegm thinner ...
(Date:9/3/2015)... , Sept. 3, 2015  CVS Health Corporation ... Merlo , the company,s president and chief executive officer, ... chief financial officer, will be speaking to investors at ... 17, 2015. They are scheduled to speak at approximately ... the presentation will be broadcast simultaneously through the Investor ...
(Date:9/3/2015)... 03, 2015 Research and ... the "Investigation Report on China Oxiracetam Market, 2010-2019" ... derivative of pyrrolidone, was first synthesized by ISF in ... and injection entered the Italian market respectively in 1987 ... China , annual sales rising from ...
Breaking Medicine Technology:China Bromhexine Market Report 2015-2019 2Investigation Report on China's Oxiracetam Market, 2010-2019 2
(Date:9/3/2015)... ... September 03, 2015 , ... Topical BioMedics, Inc., ... destination of his six-month, 10,000 mile journey from Santiago, Chile to Times Square ... calls the “Connecting Las Americas” project—Max crossed six countries in 168 days on ...
(Date:9/3/2015)... ... September 03, 2015 , ... Real Time Pain Relief ... professional bull rider David Mason has signed an official endorsement deal with the company. ... of six and his first bull at 15. He is an Australian bull riding ...
(Date:9/3/2015)... PEACHTREE CITY, GA (PRWEB) , ... September 03, ... ... does not cover the cost of graduated compression garments. However, graduated compression garments ... management. , Wound care and lymphedema specialist, Robyn Bjork, was recently sponsored by ...
(Date:9/3/2015)... ... September 03, 2015 , ... The first part of ... allegations made by IVC filter lawsuits filed against Bard.** These lawsuits, filed ... a Bard IVC filter broke or failed, have recently been consolidated for pretrial proceedings ...
(Date:9/3/2015)... ... September 03, 2015 , ... ... comprehensive eating disorder treatment for adults and adolescents struggling with anorexia, bulimia, ... has joined the medical treatment team. As a Staff Psychiatrist, Dr. Calinoiu ...
Breaking Medicine News(10 mins):Health News:Topical BioMedics Announces Visit from Max Wohlgemuth Kitslaar, Ending his Six-Month, 10,000 Mile Journey from Chile to New York on a 1976 Moto Guzzi Motorcycle 2Health News:Topical BioMedics Announces Visit from Max Wohlgemuth Kitslaar, Ending his Six-Month, 10,000 Mile Journey from Chile to New York on a 1976 Moto Guzzi Motorcycle 3Health News:Topical BioMedics Announces Visit from Max Wohlgemuth Kitslaar, Ending his Six-Month, 10,000 Mile Journey from Chile to New York on a 1976 Moto Guzzi Motorcycle 4Health News:Topical BioMedics Announces Visit from Max Wohlgemuth Kitslaar, Ending his Six-Month, 10,000 Mile Journey from Chile to New York on a 1976 Moto Guzzi Motorcycle 5Health News:Topical BioMedics Announces Visit from Max Wohlgemuth Kitslaar, Ending his Six-Month, 10,000 Mile Journey from Chile to New York on a 1976 Moto Guzzi Motorcycle 6Health News:Real Time Pain Relief Sponsors the Talented PBR Bull Rider from Down Under - David Mason 2Health News:Real Time Pain Relief Sponsors the Talented PBR Bull Rider from Down Under - David Mason 3Health News:SIGVARIS Supports the Lymphedema Treatment Act to Help Patients with Lymphedema 2Health News:SIGVARIS Supports the Lymphedema Treatment Act to Help Patients with Lymphedema 3Health News:Bard IVC Lawsuit Allegations Reach National Prime Time News 2Health News:Bard IVC Lawsuit Allegations Reach National Prime Time News 3Health News:Ileana Calinoiu, MD Joins Eating Recovery Center of Washington Medical Treatment Team 2Health News:Ileana Calinoiu, MD Joins Eating Recovery Center of Washington Medical Treatment Team 3
... ... 100 Attorneys in New England - Result of Peer-review Process , , ... Boston, MA (PRWEB) December 9, 2009 -- Boston medical malpractice ... named among the "Top 100" lawyers in New England for 2009 as listed by Super Lawyers ...
... Beverly ... Face Institute, to The Big Apple. A world famous rhinoplasty and facelift surgeon as featured ... East Coast and West Coast patients. , ... Rancho Cucamonga, CA (PRWEB) December 9, 2009 -- Southern California facial plastic ...
... , March of Dimes Polls Moms On Their ... 9 Moms worry. Even before they become moms. From the minute they ... the birth, moms worry. , Will my baby be healthy? Will I ... I eat? , The March of Dimes polled about 1,200 moms to ...
... Dec. 8 Beckman Coulter, Inc. (NYSE: BEC ... simplify, automate, and innovate complex biomedical tests, will host its ... Thursday, December 17, 2009, from 2:30 p.m. to 5:00 p.m. ... Charlie Slacik, chief financial officer, and other corporate executives will ...
... ... , ... (PRWEB) December 8, 2009 -- Many parents dread the holiday season as they struggle ... parents worried and isolated. Rather than celebrating the holiday season, parents are concerned ...
... Healthcare consultant partners with Laguna Honda Hospital ... Health , SAN FRANCISCO, Dec. 8 ... on a new 11-month contract with The City and County ... model of care and organizational effectiveness development program for the ...
Cached Medicine News:Health News:Andrew C. Meyer, Jr. and Robert M. Higgins Named Top 100 New England Super Lawyers 2Health News:Dr. 90210 Rhinoplasty Specialist Now Accommodates Both the East and West Coast 2Health News:Sushi & Breastfeeding Join Birth Defects & Preterm Birth as Leading Concerns of Moms 2Health News:Beckman Coulter to Host Annual Business Review 2Health News:Book Offers Help for Parents Struggling with Difficult Teens During the Upcoming Holidays 2Health News:Lumetra Healthcare Solutions Begins Contract With City and County of San Francisco 2Health News:Lumetra Healthcare Solutions Begins Contract With City and County of San Francisco 3
Nucleus divider with 1.25 mm tip and blade offset at a 60 degree angle is ideal for performing the "Phaco Chop" technique to be used in left hand. Round knurled handle....
Flat 7 mm wide hook. Flat serrated handle with polished finish. Overall length: 5.1 inches....
#2 10 mm hook. Flat serrated handle with polished finish. Overall length: 5.5 inches....
Small bulbous tip with flat sides. Flat serrated handle with polished finish. Overall length: 5.1 inches....
Medicine Products: